Skip to content

Moderna controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2020

    Moderna reports vaccine documents accessed in cyberattack

    Issue disclosure

    Moderna stated that the European Medicines Agency informed it that certain documents related to pre-submission discussions about its COVID-19 vaccine candidate had been unlawfully accessed in a cyberattack on the regulator. According to Moderna, its submission did not include information identifying individual study participants. The company disclosed the notification without providing further details on the accessed documents or the attack itself.

    Moderna said the European Medicines Agency informed it that certain documents related to pre-submission discussions about its COVID-19 vaccine candidate had been unlawfully accessed in a cyberattack on the regulator. Moderna said its submission did not include information identifying individual study participants.

    Source excerpt

    • Moderna Inc has recently stated that it was informed by the official European Medicine Agency or EMA that certain documents that were related to the pre-submission talks of its own COVID-19 vaccine candidate were said to be unlawfully accessed in a cyberattack on the known medicines regulator.
    • Moderna has stated that its submission to the EMA actually did not include any information that identified certain individual study participants.